What is Fios Genomics?
Fios Genomics provides comprehensive bioinformatics data analysis services, catering to pharmaceutical companies, contract research organizations (CROs), and academic institutions. Their expertise spans gene expression, single-cell analysis, and proteomics, aiming to convert complex biological data into actionable insights that accelerate drug discovery and validation. The company's commitment to sustainability is also highlighted by its participation in the SME Climate Hub.
How much funding has Fios Genomics raised?
Fios Genomics has raised a total of $2.8M across 4 funding rounds:
Private Equity
$817K
Series B
$710K
Other Financing Round
$795K
Series C
$509K
Private Equity (2011): $817K with participation from Archangel Informal Investment and Scottish Enterprise
Series B (2011): $710K led by Archangels and TRICAPITAL
Other Financing Round (2013): $795K supported by Archangel and Tweed Renaissance Investors Capital
Series C (2014): $509K featuring Tweed Renaissance Investors Capital
Key Investors in Fios Genomics
Archangel Informal Investment
Archangel Informal Investment is an early-stage investment firm known for backing innovative companies, likely focusing on technology and life sciences ventures.
Scottish Enterprise
Scottish Enterprise is a national economic development agency dedicated to supporting Scottish businesses and fostering economic growth, often investing in promising local companies.
Tweed Renaissance Investors Capital
Tweed Renaissance Investors Capital (TRI Cap) is a business angel syndicate that invests in growth-oriented businesses, particularly within Scotland, providing capital and strategic guidance.
What's next for Fios Genomics?
With significant enterprise-level backing, Fios Genomics is poised to expand its analytical capabilities and market reach. The strategic capital infusion will likely fuel advancements in their service offerings, enabling deeper insights into complex biological datasets and further solidifying their position as a key partner in the pharmaceutical and biotech innovation ecosystem. Future growth may involve enhancing AI-driven analytics and broadening their client base.
See full Fios Genomics company page
